- SEK117.62m
- SEK104.24m
- SEK156.81m
- 91
- 74
- 10
- 62
Annual balance sheet for Arcoma AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | — | — | — | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 8.58 | 4.83 | 9.66 | 5 | 13.4 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 23.8 | 17.1 | 26.5 | 19.3 | 17.6 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 58.5 | 43.2 | 66.9 | 54.7 | 57.4 |
Net Property, Plant And Equipment | 1.36 | 1.89 | 1.64 | 1.39 | 1.14 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 95 | 79.3 | 100 | 82 | 80.5 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 42.8 | 33 | 50.4 | 31.2 | 21.1 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 45.5 | 35.2 | 54.5 | 33.3 | 21.1 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 49.5 | 44 | 45.9 | 48.7 | 59.3 |
Total Liabilities & Shareholders' Equity | 95 | 79.3 | 100 | 82 | 80.5 |
Total Common Shares Outstanding |